Cargando…

Concomitant constitutive LNK and NFE2 mutation with loss of sumoylation in a case of hereditary thrombocythemia

Detalles Bibliográficos
Autores principales:	Böckelmann, Lukas Clemens, Basu, Titiksha, Gründer, Albert, Wang, Wei, Breucker, Jan, Kaiser, Sandra, Pichler, Andrea, Pahl, Heike Luise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018143/ https://www.ncbi.nlm.nih.gov/pubmed/32554556 http://dx.doi.org/10.3324/haematol.2020.246587

Ejemplares similares

Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models
por: Basu, Titiksha, et al.
Publicado: (2021)

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2(V617F) mutated cells
por: Staehle, Anne Marie, et al.
Publicado: (2023)

LNK suppresses interferon signaling in melanoma
por: Ding, Ling-Wen, et al.
Publicado: (2019)

Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation
por: Jakobs, Astrid, et al.
Publicado: (2007)

COLD REGULATED GENE 27 and 28 antagonize the transcriptional activity of the RVE8/LNK1/LNK2 circadian complex
por: Sorkin, Maria L, et al.
Publicado: (2023)

Concomitant Essential Thrombocythemia and Mature B -Lymphoproliferative Disorder in a Patient
por: Butt, Ayesha, et al.
Publicado: (2021)

Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated Megakaryocytopoiesis
por: Tong, Wei, et al.
Publicado: (2004)

Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice
por: Velazquez, Laura, et al.
Publicado: (2002)

The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms
por: Chen, Yan, et al.
Publicado: (2016)

LNK (SH2B3): paradoxical effects in ovarian cancer
por: Ding, Ling-Wen, et al.
Publicado: (2014)

The LNK Gene Family: At the Crossroad between Light Signaling and the Circadian Clock
por: de Leone, María José, et al.
Publicado: (2018)

Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK
por: Morris, Rhiannon, et al.
Publicado: (2021)

Enhanced Hematopoiesis by Hematopoietic Progenitor Cells Lacking Intracellular Adaptor Protein, Lnk
por: Takaki, Satoshi, et al.
Publicado: (2002)

On Syphilis, Constitutional and Hereditary; and on Syphilitic Eruptions
Publicado: (1852)

On Syphilis, Constitutional and Hereditary; and on Syphilitic Eruptions
Publicado: (1853)

Lnk-dependent axis of SCF–cKit signal for osteogenesis in bone fracture healing
por: Matsumoto, Tomoyuki, et al.
Publicado: (2010)

Regulation of Lifespan, Metabolism, and Stress Responses by the Drosophila SH2B Protein, Lnk
por: Slack, Cathy, et al.
Publicado: (2010)

The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
por: Morris, Rhiannon, et al.
Publicado: (2021)

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice
por: Cuddy, Leah K., et al.
Publicado: (2022)

DNA end resection requires constitutive sumoylation of CtIP by CBX4
por: Soria-Bretones, Isabel, et al.
Publicado: (2017)

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Management of thrombocythemia
por: Gowin, Krisstina, et al.
Publicado: (2014)

Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency
por: Dou, Huijuan, et al.
Publicado: (2021)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

The Drosophila SH2B Family Adaptor Lnk Acts in Parallel to Chico in the Insulin Signaling Pathway
por: Werz, Christian, et al.
Publicado: (2009)

Gut Microbiota Dysbiosis Ameliorates in LNK-Deficient Mouse Models with Obesity-Induced Insulin Resistance Improvement
por: Chen, Jingbo, et al.
Publicado: (2023)

Concomitant Diagnosis of Primary Bone Marrow B-Cell Non-Hodgkin Lymphoma and Essential Thrombocythemia: A Case Report
por: Kim, Hongkyung, et al.
Publicado: (2022)

The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain
por: Basu, Paramita, et al.
Publicado: (2022)

Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer
por: López-Mejía, José A., et al.
Publicado: (2023)

A case of concomitant Gilbert's syndrome and hereditary spherocytosis
por: Lee, Hee Jung, et al.
Publicado: (2010)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Sweet's syndrome with idiopathic thrombocythemia
por: Kaszewski, Sebastian, et al.
Publicado: (2014)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

NFE2L2 polymorphisms, mortality, and metabolism in the general population
por: Figarska, Sylwia M., et al.
Publicado: (2014)

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
por: Forcina, Giovanni C., et al.
Publicado: (2022)

The Lnk/SH2B adaptor provides a fail-safe mechanism to establish the Insulin receptor-Chico interaction
por: Almudi, Isabel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mh9kbi2noonniojs8hb7951s5d